These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26147338)

  • 1. New Perspective in the Formulation and Characterization of Didodecyldimethylammonium Bromide (DMAB) Stabilized Poly(Lactic-co-Glycolic Acid) (PLGA) Nanoparticles.
    Gossmann R; Langer K; Mulac D
    PLoS One; 2015; 10(7):e0127532. PubMed ID: 26147338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative examination of adsorption of serum proteins on HSA- and PLGA-based nanoparticles using SDS-PAGE and LC-MS.
    Gossmann R; Fahrländer E; Hummel M; Mulac D; Brockmeyer J; Langer K
    Eur J Pharm Biopharm; 2015 Jun; 93():80-7. PubMed ID: 25813886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved delivery of the natural anticancer drug tetrandrine.
    Shi C; Ahmad Khan S; Wang K; Schneider M
    Int J Pharm; 2015 Feb; 479(1):41-51. PubMed ID: 25510598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene delivery using dimethyldidodecylammonium bromide-coated PLGA nanoparticles.
    Fay F; Quinn DJ; Gilmore BF; McCarron PA; Scott CJ
    Biomaterials; 2010 May; 31(14):4214-22. PubMed ID: 20185174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering of a novel adjuvant based on lipid-polymer hybrid nanoparticles: A quality-by-design approach.
    Rose F; Wern JE; Ingvarsson PT; van de Weert M; Andersen P; Follmann F; Foged C
    J Control Release; 2015 Jul; 210():48-57. PubMed ID: 25957906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Transport of PLGA nanoparticles across Caco-2/HT29-MTX co-cultured cells].
    Wen Z; Li G; Lin DH; Wang JT; Qin LF; Guo GP
    Yao Xue Xue Bao; 2013 Dec; 48(12):1829-35. PubMed ID: 24689242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of biodegradable nanoparticles for oral delivery of ellagic acid and evaluation of their antioxidant efficacy against cyclosporine A-induced nephrotoxicity in rats.
    Sonaje K; Italia JL; Sharma G; Bhardwaj V; Tikoo K; Kumar MN
    Pharm Res; 2007 May; 24(5):899-908. PubMed ID: 17377747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A physical model for the size-dependent cellular uptake of nanoparticles modified with cationic surfactants.
    Xu A; Yao M; Xu G; Ying J; Ma W; Li B; Jin Y
    Int J Nanomedicine; 2012; 7():3547-54. PubMed ID: 22848178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of estradiol loaded PLGA nanoparticulate formulations: a potential oral delivery system for hormone therapy.
    Hariharan S; Bhardwaj V; Bala I; Sitterberg J; Bakowsky U; Ravi Kumar MN
    Pharm Res; 2006 Jan; 23(1):184-95. PubMed ID: 16267632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of surfactant on glass transition temperature of poly(lactic-
    Liu G; Martinez R; Bhatnagar A; McEnnis K
    Soft Matter; 2023 Jul; 19(28):5371-5378. PubMed ID: 37409398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface coverage of didecyl dimethylammonium bromide on poly(lactide-co-glycolide) nanoparticles.
    Kuo YC; Yu HW
    Colloids Surf B Biointerfaces; 2011 May; 84(1):253-8. PubMed ID: 21288700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of the degree of pegylation of poly(lactic-co-glycolic acid) nanoparticles in enhancing central nervous system delivery of loperamide.
    Kirby BP; Pabari R; Chen CN; Al Baharna M; Walsh J; Ramtoola Z
    J Pharm Pharmacol; 2013 Oct; 65(10):1473-81. PubMed ID: 24028614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Surface-modified paclitaxel-loaded nanoparticles as local delivery system for the prevention of vessel restenosis].
    Mei L; Song CX; Jin X; Che YZ; Jin Z; Sun HF
    Yao Xue Xue Bao; 2007 Jan; 42(1):81-6. PubMed ID: 17520813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration.
    Zhang X; Sun M; Zheng A; Cao D; Bi Y; Sun J
    Eur J Pharm Sci; 2012 Apr; 45(5):632-8. PubMed ID: 22248882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PLGA nanoparticles for oral delivery of hydrophobic drugs: influence of organic solvent on nanoparticle formation and release behavior in vitro and in vivo using estradiol as a model drug.
    Sahana DK; Mittal G; Bhardwaj V; Kumar MN
    J Pharm Sci; 2008 Apr; 97(4):1530-42. PubMed ID: 17722098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and in vitro evaluation of thienorphine-loaded PLGA nanoparticles.
    Yang Y; Xie XY; Mei XG
    Drug Deliv; 2016; 23(3):787-93. PubMed ID: 24870204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
    Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B
    Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of formulation variables on preparation of celecoxib loaded polylactide-co-glycolide nanoparticles.
    Cooper DL; Harirforoosh S
    PLoS One; 2014; 9(12):e113558. PubMed ID: 25502102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs.
    Win KY; Feng SS
    Biomaterials; 2005 May; 26(15):2713-22. PubMed ID: 15585275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrafine PEG-coated poly(lactic-co-glycolic acid) nanoparticles formulated by hydrophobic surfactant-assisted one-pot synthesis for biomedical applications.
    Chu CH; Wang YC; Huang HY; Wu LC; Yang CS
    Nanotechnology; 2011 May; 22(18):185601. PubMed ID: 21415469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.